Role of anti-recoverin autoantibodies in cancer-associated retinopathy

Grazyna Adamus, J. Guy, J. L. Schmied, A. Arendt, P. A. Hargrave

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Purpose. To examine the retina and test the serum of a patient with cancer-associated retinopathy syndrome who was diagnosed with small cell carcinoma of the lung and experienced unexpected visual loss. Methods. Proteins from normal human retina were extracted, separated by one- and two- dimensional gel electrophoresis, transferred to PVDF membrane, and used for immunostaining. Antibody specificity was determined by use of solid-phase peptides in a solid-phase immunoassay. Results. Histologic examination of the retina showed loss of the photoreceptor cell layer. This finding correlated with the results of clinical (loss of vision) and electrophysiologic (abnormal electroretinograph [ERG]) tests. The patient's serum antibodies specifically recognized recoverin, a protein predominantly found in retinal photoreceptor cells. The patient's serum also labeled some higher molecular weight proteins present in normal lung and other normal tissues, as well as in lung cell carcinoma cell lines. The only other tissue in which immunoreactivity against p23 could be found was the optic nerve. Our data revealed a lack of cross-reactivity between specific anti-recoverin antibodies and lung proteins. The results indicate that the patient serum contains more than one type of antibody activity. The autoantibodies were tested for fine immunospecificity by use of solid-phase peptides in a solid- phase immunoassay. Patient's antibodies reacted with a major determinant located in the recoverin sequence 62-68 (PKAYAQH) and with several minor ones. Conclusion. Based on the fact that the recoverin appears to be distributed in several different cell types, we suggest that this protein may be present in cancer cells and may play a role in the pathogenesis of some cancer-associated retinopathies.

Original languageEnglish (US)
Pages (from-to)2626-2633
Number of pages8
JournalInvestigative Ophthalmology and Visual Science
Volume34
Issue number9
StatePublished - 1993
Externally publishedYes

Fingerprint

Ocular Paraneoplastic Syndromes
Recoverin
Autoantibodies
Retina
Proteins
Serum
Immunoassay
Lung
Antibodies
Photoreceptor Cells
Peptides
Vertebrate Photoreceptor Cells
Antibody Specificity
Small Cell Lung Carcinoma
Electrophoresis, Gel, Two-Dimensional
Optic Nerve
Anti-Idiotypic Antibodies
Molecular Weight
Carcinoma
Cell Line

Keywords

  • autoantibody
  • autoimmunity
  • cancer-associated retinopathy
  • CAR antigen
  • recoverin

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Adamus, G., Guy, J., Schmied, J. L., Arendt, A., & Hargrave, P. A. (1993). Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Investigative Ophthalmology and Visual Science, 34(9), 2626-2633.

Role of anti-recoverin autoantibodies in cancer-associated retinopathy. / Adamus, Grazyna; Guy, J.; Schmied, J. L.; Arendt, A.; Hargrave, P. A.

In: Investigative Ophthalmology and Visual Science, Vol. 34, No. 9, 1993, p. 2626-2633.

Research output: Contribution to journalArticle

Adamus, G, Guy, J, Schmied, JL, Arendt, A & Hargrave, PA 1993, 'Role of anti-recoverin autoantibodies in cancer-associated retinopathy', Investigative Ophthalmology and Visual Science, vol. 34, no. 9, pp. 2626-2633.
Adamus, Grazyna ; Guy, J. ; Schmied, J. L. ; Arendt, A. ; Hargrave, P. A. / Role of anti-recoverin autoantibodies in cancer-associated retinopathy. In: Investigative Ophthalmology and Visual Science. 1993 ; Vol. 34, No. 9. pp. 2626-2633.
@article{4e93e646991d4f618aea24bb40f7d075,
title = "Role of anti-recoverin autoantibodies in cancer-associated retinopathy",
abstract = "Purpose. To examine the retina and test the serum of a patient with cancer-associated retinopathy syndrome who was diagnosed with small cell carcinoma of the lung and experienced unexpected visual loss. Methods. Proteins from normal human retina were extracted, separated by one- and two- dimensional gel electrophoresis, transferred to PVDF membrane, and used for immunostaining. Antibody specificity was determined by use of solid-phase peptides in a solid-phase immunoassay. Results. Histologic examination of the retina showed loss of the photoreceptor cell layer. This finding correlated with the results of clinical (loss of vision) and electrophysiologic (abnormal electroretinograph [ERG]) tests. The patient's serum antibodies specifically recognized recoverin, a protein predominantly found in retinal photoreceptor cells. The patient's serum also labeled some higher molecular weight proteins present in normal lung and other normal tissues, as well as in lung cell carcinoma cell lines. The only other tissue in which immunoreactivity against p23 could be found was the optic nerve. Our data revealed a lack of cross-reactivity between specific anti-recoverin antibodies and lung proteins. The results indicate that the patient serum contains more than one type of antibody activity. The autoantibodies were tested for fine immunospecificity by use of solid-phase peptides in a solid- phase immunoassay. Patient's antibodies reacted with a major determinant located in the recoverin sequence 62-68 (PKAYAQH) and with several minor ones. Conclusion. Based on the fact that the recoverin appears to be distributed in several different cell types, we suggest that this protein may be present in cancer cells and may play a role in the pathogenesis of some cancer-associated retinopathies.",
keywords = "autoantibody, autoimmunity, cancer-associated retinopathy, CAR antigen, recoverin",
author = "Grazyna Adamus and J. Guy and Schmied, {J. L.} and A. Arendt and Hargrave, {P. A.}",
year = "1993",
language = "English (US)",
volume = "34",
pages = "2626--2633",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "9",

}

TY - JOUR

T1 - Role of anti-recoverin autoantibodies in cancer-associated retinopathy

AU - Adamus, Grazyna

AU - Guy, J.

AU - Schmied, J. L.

AU - Arendt, A.

AU - Hargrave, P. A.

PY - 1993

Y1 - 1993

N2 - Purpose. To examine the retina and test the serum of a patient with cancer-associated retinopathy syndrome who was diagnosed with small cell carcinoma of the lung and experienced unexpected visual loss. Methods. Proteins from normal human retina were extracted, separated by one- and two- dimensional gel electrophoresis, transferred to PVDF membrane, and used for immunostaining. Antibody specificity was determined by use of solid-phase peptides in a solid-phase immunoassay. Results. Histologic examination of the retina showed loss of the photoreceptor cell layer. This finding correlated with the results of clinical (loss of vision) and electrophysiologic (abnormal electroretinograph [ERG]) tests. The patient's serum antibodies specifically recognized recoverin, a protein predominantly found in retinal photoreceptor cells. The patient's serum also labeled some higher molecular weight proteins present in normal lung and other normal tissues, as well as in lung cell carcinoma cell lines. The only other tissue in which immunoreactivity against p23 could be found was the optic nerve. Our data revealed a lack of cross-reactivity between specific anti-recoverin antibodies and lung proteins. The results indicate that the patient serum contains more than one type of antibody activity. The autoantibodies were tested for fine immunospecificity by use of solid-phase peptides in a solid- phase immunoassay. Patient's antibodies reacted with a major determinant located in the recoverin sequence 62-68 (PKAYAQH) and with several minor ones. Conclusion. Based on the fact that the recoverin appears to be distributed in several different cell types, we suggest that this protein may be present in cancer cells and may play a role in the pathogenesis of some cancer-associated retinopathies.

AB - Purpose. To examine the retina and test the serum of a patient with cancer-associated retinopathy syndrome who was diagnosed with small cell carcinoma of the lung and experienced unexpected visual loss. Methods. Proteins from normal human retina were extracted, separated by one- and two- dimensional gel electrophoresis, transferred to PVDF membrane, and used for immunostaining. Antibody specificity was determined by use of solid-phase peptides in a solid-phase immunoassay. Results. Histologic examination of the retina showed loss of the photoreceptor cell layer. This finding correlated with the results of clinical (loss of vision) and electrophysiologic (abnormal electroretinograph [ERG]) tests. The patient's serum antibodies specifically recognized recoverin, a protein predominantly found in retinal photoreceptor cells. The patient's serum also labeled some higher molecular weight proteins present in normal lung and other normal tissues, as well as in lung cell carcinoma cell lines. The only other tissue in which immunoreactivity against p23 could be found was the optic nerve. Our data revealed a lack of cross-reactivity between specific anti-recoverin antibodies and lung proteins. The results indicate that the patient serum contains more than one type of antibody activity. The autoantibodies were tested for fine immunospecificity by use of solid-phase peptides in a solid- phase immunoassay. Patient's antibodies reacted with a major determinant located in the recoverin sequence 62-68 (PKAYAQH) and with several minor ones. Conclusion. Based on the fact that the recoverin appears to be distributed in several different cell types, we suggest that this protein may be present in cancer cells and may play a role in the pathogenesis of some cancer-associated retinopathies.

KW - autoantibody

KW - autoimmunity

KW - cancer-associated retinopathy

KW - CAR antigen

KW - recoverin

UR - http://www.scopus.com/inward/record.url?scp=0027328916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027328916&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 2626

EP - 2633

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 9

ER -